{"id":12715,"date":"2013-04-13T23:53:38","date_gmt":"2013-04-14T03:53:38","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/research-and-markets-plaque-psoriasis-psoriasis-vulgaris-pipeline-review-h1-2013\/"},"modified":"2013-04-13T23:53:38","modified_gmt":"2013-04-14T03:53:38","slug":"research-and-markets-plaque-psoriasis-psoriasis-vulgaris-pipeline-review-h1-2013","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-plaque-psoriasis-psoriasis-vulgaris-pipeline-review-h1-2013\/","title":{"rendered":"Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) &#8211; Pipeline Review, H1 2013"},"content":{"rendered":"<p><p>    DUBLIN--(BUSINESS WIRE)--  <\/p>\n<p>    Research and Markets has announced the    addition of the     \"Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1    2013\" report to their offering.  <\/p>\n<p>    Global Markets Direct's, 'Plaque Psoriasis (Psoriasis Vulgaris)    - Pipeline Review, H1 2013', provides an overview of the    indication's therapeutic pipeline. This report provides    information on the therapeutic development for Plaque Psoriasis    (Psoriasis Vulgaris), complete with latest updates, and special    features on late-stage and discontinued projects. It also    reviews key players involved in the therapeutic development for    Plaque Psoriasis (Psoriasis Vulgaris). Plaque Psoriasis    (Psoriasis Vulgaris) - Pipeline Review, Half Year is built    using data and information sourced from Global Markets Direct's    proprietary databases, Company\/University websites, SEC    filings, investor presentations and featured press releases    from company\/university sites and industry-specific third party    sources, put together by Global Markets Direct's team.  <\/p>\n<p>    Scope  <\/p>\n<p>    - A snapshot of the global therapeutic scenario for Plaque    Psoriasis (Psoriasis Vulgaris).  <\/p>\n<p>    - A review of the Plaque Psoriasis (Psoriasis Vulgaris)    products under development by companies and    universities\/research institutes based on information derived    from company and industry-specific sources.  <\/p>\n<p>    - Coverage of products based on various stages of development    ranging from discovery till registration stages.  <\/p>\n<p>    - A feature on pipeline projects on the basis of monotherapy    and combined therapeutics.  <\/p>\n<p>    - Coverage of the Plaque Psoriasis (Psoriasis Vulgaris)    pipeline on the basis of route of administration and molecule    type.  <\/p>\n<p>    - Key discontinued pipeline projects.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/research-markets-plaque-psoriasis-psoriasis-004200466.html;_ylt=A2KLOzI3KGpRkRoARgP_wgt.\" title=\"Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013\">Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the \"Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013\" report to their offering. Global Markets Direct's, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-plaque-psoriasis-psoriasis-vulgaris-pipeline-review-h1-2013\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-12715","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/12715"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=12715"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/12715\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=12715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=12715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=12715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}